Antioxidant Properties
Green tea supplements are rich in catechins, particularly EGCG, which neutralize free radicals, reducing oxidative stress and potentially protecting against cellular damage linked to aging and chronic diseases.
Weight Management Support
Catechins and caffeine in green tea may enhance metabolism and fat oxidation, modestly aiding weight loss or maintenance when combined with a healthy diet and exercise. Studies show small but significant effects on body weight and fat reduction.
Cardiovascular Health
Green tea supplements may improve heart health by reducing LDL ("bad") cholesterol levels, lowering blood pressure, and improving blood vessel function, potentially decreasing the risk of heart disease.
Cognitive Function
Compounds like EGCG and L-theanine may support brain health, improving focus, memory, and mood while potentially reducing the risk of neurodegenerative diseases like Alzheimer’s, though more research is needed.
Anti-Inflammatory and Immune Support
Polyphenols in green tea have anti-inflammatory properties and may modulate immune responses, potentially aiding in overall immune health and reducing inflammation-related conditions.
Antioxidant Activity
Catechins, especially EGCG, act as potent antioxidants by scavenging free radicals and reducing oxidative stress. They inhibit reactive oxygen species (ROS) and upregulate antioxidant enzymes, protecting cells from damage linked to aging and chronic diseases.
Metabolic Enhancement for Weight Management
EGCG and caffeine stimulate thermogenesis and fat oxidation by inhibiting the enzyme catechol-O-methyltransferase (COMT), which prolongs the activity of norepinephrine, a hormone that boosts metabolism. This increases energy expenditure and fat breakdown, supporting weight loss.
Cardiovascular Benefits
Catechins improve lipid metabolism by reducing LDL cholesterol oxidation and inhibiting cholesterol absorption in the gut. They also enhance endothelial function by increasing nitric oxide production, which promotes vasodilation and lowers blood pressure, reducing cardiovascular risk.
Neuroprotective Effects
EGCG crosses the blood-brain barrier and may protect neurons by reducing oxidative stress and inflammation. L-theanine promotes alpha brain wave activity, enhancing relaxation and focus, while caffeine improves alertness by blocking adenosine receptors.
Anti-Inflammatory and Immune Modulation
Catechins inhibit pro-inflammatory pathways (e.g., NF-κB) and modulate immune cell activity, reducing inflammation and potentially enhancing immune responses. This may help manage inflammatory conditions and support overall immunity.
Study: A 2021 randomized, placebo-controlled, double-blind, parallel-group trial (NCT03628937) in Japan involving 60 healthy adults (aged 30–75) with BMI ≥23 kg/m². Participants consumed green tea with α-glucosyl hesperidin (GT-gH, containing 146 mg EGCG and 178 mg α-glucosyl hesperidin) or placebo daily for 12 weeks. Outcomes included visceral fat area (VFA), body weight, BMI, and lipid profiles.
Findings: GT-gH significantly reduced VFA (mean difference: -7.2 cm², p=0.019) and body weight (p<0.05) compared to placebo. Lipid profiles (e.g., LDL cholesterol) improved slightly. Safety assessments (vital signs, hematology, liver/renal function) showed no significant differences between groups. Side effects were minimal, with no serious adverse events; mild gastrointestinal issues (e.g., bloating) were reported in some participants.
Link: Nature - Combined Effect of Green Tea and α-Glucosyl Hesperidin
2021 meta-analysis of 16 RCTs (17 arms, 760 participants) evaluating green tea's effects on oxidative stress markers including total antioxidant capacity (TAC), malondialdehyde (MDA), and superoxide dismutase (SOD).
760 participants across 16 RCTs. Diverse populations including healthy adults and those with chronic conditions.
Green tea significantly increased TAC (WMD: 0.20 mmol/L, p<0.001) with effects stronger in longer interventions. Significantly reduced MDA and increased SOD. Supports green tea's antioxidant benefit in humans.
Study: A 2023 meta-analysis of 55 RCTs (63 effect sizes) investigating green tea’s effects on cardiovascular risk factors (lipid profile, blood pressure, glycemic control, CRP). Databases (PubMed, Scopus, Web of Science, Embase) were searched for RCTs. Doses varied, with subgroup analyses for <1000 mg/day vs. ≥1000 mg/day and duration (<12 vs. ≥12 weeks).
Findings: Green tea significantly reduced total cholesterol (WMD: -7.62 mg/dL, p<0.001), LDL cholesterol (WMD: -5.80 mg/dL, p<0.001), fasting blood glucose (WMD: -1.67 mg/dL, p<0.001), and increased HDL cholesterol (WMD: 1.85 mg/dL, p=0.010). Effects were stronger at doses <1000 mg/day and in females or mixed-sex groups. Side effects were not extensively detailed but included mild gastric disturbances in some trials, with no serious adverse events noted.
Link: Frontiers - Green Tea Supplementation on Cardiovascular Risk Factors
Study: A 2024 RCT (NCT03628937) in China involving 62 girls with obesity (aged 6–10). Participants received 400 mg/day decaffeinated green tea polyphenols (DGTP) or placebo for 12 weeks. Outcomes included anthropometric measures, liver/renal function, and safety parameters (e.g., vital signs, blood glucose).
Findings: DGTP showed no significant changes in body weight, BMI, or lipid profiles compared to placebo. Safety assessments confirmed no adverse effects on liver (AST, ALT), renal (BUN, creatinine), or hematological parameters. No serious adverse events were reported; mild gastrointestinal discomfort (e.g., nausea) was noted in a few participants.
Link: PMC - Decaffeinated Green Tea Polyphenols in Girls
Study: A 2017 RCT involving 45 women with PCOS, randomly assigned to green tea tablets (dose not specified) or placebo for 45 days. Outcomes included anthropometric indices (BMI, weight, waist circumference, body fat percentage) and inflammatory markers (IL-6, CRP, TNF-α).
Findings: Green tea significantly reduced BMI, weight, waist circumference, and body fat percentage within the green tea group (p<0.05), but no significant differences were observed between groups. No effect on inflammatory markers (IL-6, CRP, TNF-α). Side effects were minimal, with mild gastric disturbances reported in some participants, similar to placebo.
Link: PubMed - Green Tea in PCOS
Study: A 2018 meta-analysis of RCTs (searched up to October 2017 via PubMed, Scopus, Web of Science, Google Scholar) evaluating green tea’s effects on nonalcoholic fatty liver disease (NAFLD). Outcomes included liver enzymes (ALT, AST), lipid profiles, BMI, and insulin resistance.
Findings: Green tea significantly reduced BMI (-2.08 kg/m², 95% CI: -2.81 to -1.36), triglycerides (-31.87 mg/dL), total cholesterol (-27.57 mg/dL), and LDL cholesterol (-14.15 mg/dL). No significant effect on HDL or insulin resistance. Side effects were mild, primarily gastrointestinal (e.g., bloating, nausea), with no serious adverse events reported.
Link: PubMed - Green Tea in NAFLD